Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The Diabetes Team at the Trust that runs Shropshire’s acute hospitals scooped the Public Recognition Award at its annual ...

Ever had a boss whose requests were so infuriating, you felt like screaming into a pillow? We’ve all been there, gritting our ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the appointment of Robert ...

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

A leading diabetes expert is urging Australia to make access to a game-changing medical device easier and cheaper for those ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly ...

Haley Ticer, a teacher at Cape Central Middle School, shares how she learned to manage her diabetes diagnosis throughout ...

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.